SOW
IOBT

State of Wyoming’s IO Biotech IOBT Stock Holding History

State of Wyoming’s Portfolio IOBT Stock Details IOBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-28
Closed – – 1662
2022
Q3 		$0 Buy
+28
New +$104 ﹤0.01% 1716

Other funds holding IOBT

NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return

State of Wyoming's IOBT Position: Q4 2022 in Review

State of Wyoming sold out of IO Biotech (IOBT) in Q4 2022, closing a stake of 28 shares.

State of Wyoming first reported a position in IOBT in Q3 2022 and held it in 1 quarter. The position peaked at $0 in Q3 2022. 17 funds tracked by Wall St. Rank hold IOBT as of Q4 2022.

  • State of Wyoming reported no remaining IO Biotech position as of Q4 2022 after selling out during the quarter.
  • State of Wyoming sold 28 IO Biotech shares in Q4 2022.
  • State of Wyoming first reported a position in IO Biotech in Q3 2022 and held it in 1 quarter.
  • State of Wyoming's IO Biotech position peaked at $0 in Q3 2022.
  • 17 funds tracked by Wall St. Rank held IO Biotech as of Q4 2022.

Based on State of Wyoming's 13F filing for Q4 2022, filed 15 Feb 2023.